Libra Infusions (DHA:LIBRAINFU) Earnings Power Value (EPV): BDT (As of )


DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
20 GF Score
Price BDT647.00
View Full Analysis

What is Libra Infusions Earnings Power Value (EPV)?

Libra Infusions DHA:LIBRAINFU -0.98% 20 Earnings Power Value (EPV) is BDT as of . 20. GuruFocus rates DHA:LIBRAINFU with a GF Score™ of 20/100.

As of , Libra Infusions's earnings power value is BDT. *

* GuruFocus does not store EPV value into our database if Average Maintenance CAPEX is 0.

Margin of Safety is N/A.

The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future. Assumption: Current profitability is sustainable.


Libra Infusions  (DHA:LIBRAINFU) Earnings Power Value (EPV) Explanation

Assumption: Current profitability is sustainable.

Earnings power value (EPV) uses a very basic equation which assumes no growth, although it does rely on an assumption about the cost of capital as well as the fact that current earnings are sustainable. It also involves several adjustments to clean up the underlying Earnings figures.


Be Aware

Though using today's earnings in calculating Earnings Power Value, GuruFocus is normalizing these earnings to the business cycle. This eliminates the effects on profitability of valuing the firm at different points in the business cycle. This means that we are considering the average earnings over 5 years.


Libra Infusions Earnings Power Value (EPV) Related Terms


Libra Infusions Earnings Power Value (EPV) Historical Data

* Premium members only.

The historical data trend for Libra Infusions's Earnings Power Value (EPV) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions Earnings Power Value (EPV) Chart

Libra Infusions Annual Data
Trend
Earnings Power Value (EPV)

Libra Infusions Semi-Annual Data
Earnings Power Value (EPV)

DHA:LIBRAINFU vs SECI, LENSF, ASNB: Earnings Power Value (EPV) Comparison

For the Medical Instruments & Supplies subindustry, Libra Infusions's Earnings Power Value (EPV), along with its competitors' market caps and Earnings Power Value (EPV) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Libra Infusions Earnings Power Value (EPV) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Libra Infusions's Earnings Power Value (EPV) distribution charts can be found below:

* The bar in red indicates where Libra Infusions's Earnings Power Value (EPV) falls into.


DHA:LIBRAINFU
20GF Score
Libra Infusions Ltd DHA:LIBRAINFU
Earnings Power Value (EPV) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Libra Infusions Earnings Power Value (EPV) Calculation

Earnings Power Value also known as just Earnings Power is a valuation technique popularised by Bruce Greenwald, an authority on value investing at Columbia University. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future.

The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. This valuation tool excludes the potential growth that a company may have so that needs to be looked at separately. Since future growth is excluded from the analysis, only the maintenance capital expenditures are subtracted from after-tax EBIT (earnings before interest and taxes) and growth capex is ignored.

What does a Earnings Power Value (EPV) of BDT mean?
Libra Infusions (DHA:LIBRAINFU) has a Earnings Power Value (EPV) of BDT as of . 20. Bruce Greenwald's earnings power value focuses on current earnings without factoring in future growth. View historical data on Libra Infusions and its competitors.
Is Libra Infusions' Earnings Power Value (EPV) too high?
Libra Infusions' current Earnings Power Value (EPV) is BDT. Overall, Libra Infusions has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Libra Infusions' Earnings Power Value (EPV) compare to SECI and LENSF?
Libra Infusions' Earnings Power Value (EPV) of BDT can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Power Value (EPV) for a Medical Devices & Instruments company?
A good Earnings Power Value (EPV) depends on the Medical Devices & Instruments industry context. However, Earnings Power Value (EPV) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Power Value (EPV) mean?
A high Earnings Power Value (EPV) can signal that a stock is expensive relative to its fundamentals. Bruce Greenwald's earnings power value focuses on current earnings without factoring in future growth. View historical data on Libra Infusions and its competitors. Libra Infusions's current Earnings Power Value (EPV) is BDT. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Libra Infusions stock overvalued right now?
Libra Infusions (DHA:LIBRAINFU) has a current Earnings Power Value (EPV) of BDT. The current Earnings Power Value (EPV) is BDT. Libra Infusions' overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Power Value (EPV) calculated?
Earnings Power Value (EPV) is calculated from a company's financial statements. For Libra Infusions (DHA:LIBRAINFU), the current Earnings Power Value (EPV) is BDT as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
20GF Score

Get the complete analysis for DHA:LIBRAINFU

Earnings Power Value (EPV) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT647.00
Price